The Research
How Cetyl Myristoleate Works
Myristin® is a drug-free approach to pain management.
Myristin® was born from Harry W. Diehl, Ph.D., who was concerned for a neighbor who was struggling with pain and disability. Through countless experiments and testing, cetyl myristoleate was discovered to increase mobility, reduce inflammation, and manage joint pain to increase mobility.
CMO research has been published across many peer-reviewed journals documenting the outcomes.
Benefits
Joint pain relief
Joint inflammation relief
Joint stiffness relief
Proven to support joint health to live an active lifestyle
Backed by Science
Cetyl Myristoleate was discovered in 1964 after two years of scientific investigation and exhaustive analyses by Harry W. Diehl, Ph.D. who was a researcher at the National Institute of Health.
After countless experiments, reactions, and purifications, the immunity factor was identified, through gas chromatography and mass spectrophotometry, as cetyl myristoleate.
Diehl's research on cetyl myristoleate was published in the March 1994 issue of the American Journal of Pharmaceutical Sciences, the prestigious peer-reviewed journal of the American Pharmaceutical Association and the American Chemical Society. Diehl received two U. S. Patents on cetyl myristoleate, the first in 1977 and a second in 1996.
